MAPT and Alzheimer disease: In the context of AD pathogenesis, microglial activation is a double-edged sword; it can facilitate the clearance of Aβ and tau, while potentially inducing neuroinflammation leading to neuronal damages associated with AD (Lue et al., 2010; Leyns and Holtzman, 2017; Shippy and Ulland, 2020).